Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors
- PMID: 19796495
- DOI: 10.3727/096368909X470801
Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors
Abstract
Parkinson's disease (PD) is a common neurodegenerative disease characterized by the selective loss of dopaminergic (DA) neurons in the midbrain. Various types of stem cells that have potential to differentiate into DA neurons are being investigated as cellular therapies for PD. Stem cells also secrete growth factors and therefore also may have therapeutic effects in promoting the health of diseased DA neurons in the PD brain. To address this possibility in an experimental model of PD, bone marrow-derived neuroprogenitor-like cells were generated from bone marrow procured from healthy human adult volunteers and their potential to elicit recovery of damaged DA axons was studied in a partial lesion rat model of PD. Following collection of bone marrow, mesenchymal stem cells (MSC) were isolated and then genetically modified to create SB623 cells by transient transfection with the intracellular domain of the Notch1 gene (NICD), a modification that upregulates expression of certain neuroprogenitor markers. Ten deposits of 0.5 microl of SB623 cell suspension adjusted from 6,000 to 21,000 cells/microl in PBS or PBS alone were stereotaxically placed in the striatum 1 week after the nigrostriatal projection had been partially lesioned in adult F344 rats by injection of 6-hydroxydopamine (6-OHDA) into the striatum. At 3 weeks, a small number of grafted SB623 cells survived in the lesioned striatum as visualized by expression of the human specific nuclear matrix protein (hNuMA). In rats that received SB623 cells, but not in control rats, dense tyrosine hydroxylase immunoreactive (TH-ir) fibers were observed around the grafts. These fibers appeared to be rejuvenated host DA axons because no TH-ir in soma of surviving SB623 cells or coexpression of TH and hNuMA-ir were observed. In addition, dense serotonin immunoreactive (5-HT-ir) fibers were observed around grafted SB623 cells and these fibers also appeared to be of the host origin. Also, in some SB623 grafted rats that were sacrificed within 2 h of dl-amphetamine injection, hot spots of c-Fos-positive nuclei that coincided with rejuvenated dense TH fibers around the grafted SB623 cells were observed, suggesting increased availability of DA in these locations. Our observations suggest that NICD-transfected MSC hold potential as a readily available autologous or allogenic cellular therapy for ameliorating the degeneration of DA and 5-HT neurons in PD patients.
Similar articles
-
Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.J Neurosci Res. 2010 Sep;88(12):2669-81. doi: 10.1002/jnr.22435. J Neurosci Res. 2010. PMID: 20544825
-
Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.Exp Neurol. 2000 Nov;166(1):1-15. doi: 10.1006/exnr.2000.7463. Exp Neurol. 2000. PMID: 11031079
-
Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.Neurosurgery. 2009 Oct;65(4):741-53; discussion 753. doi: 10.1227/01.NEU.0000351281.45986.76. Neurosurgery. 2009. PMID: 19834380
-
Cell transplantation in the damaged adult brain.Rev Neurol (Paris). 2013 Nov;169(11):838-43. doi: 10.1016/j.neurol.2013.07.026. Epub 2013 Oct 7. Rev Neurol (Paris). 2013. PMID: 24112517 Review.
-
Restorative strategies for the dopaminergic nigrostriatal projection pathway.Acta Neurochir Suppl. 2013;117:79-85. doi: 10.1007/978-3-7091-1482-7_13. Acta Neurochir Suppl. 2013. PMID: 23652661 Review.
Cited by
-
Quantitative microplate assay for studying mesenchymal stromal cell-induced neuropoiesis.Stem Cells Transl Med. 2013 Mar;2(3):223-32. doi: 10.5966/sctm.2012-0119. Epub 2013 Feb 19. Stem Cells Transl Med. 2013. PMID: 23430693 Free PMC article.
-
Genetic engineering of mesenchymal stem cells and its application in human disease therapy.Hum Gene Ther. 2010 Nov;21(11):1513-26. doi: 10.1089/hum.2010.165. Epub 2010 Oct 22. Hum Gene Ther. 2010. PMID: 20825283 Free PMC article. Review.
-
Comparing the immunosuppressive potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells.J Neuroinflammation. 2011 Oct 7;8:133. doi: 10.1186/1742-2094-8-133. J Neuroinflammation. 2011. PMID: 21982515 Free PMC article.
-
Adult rat mesenchymal stem cells delay denervated muscle atrophy.Cell Mol Neurobiol. 2012 Nov;32(8):1287-98. doi: 10.1007/s10571-012-9853-z. Epub 2012 Jul 10. Cell Mol Neurobiol. 2012. PMID: 22777537 Free PMC article.
-
Stem cell-based neuroprotective and neurorestorative strategies.Int J Mol Sci. 2010 May 5;11(5):2039-55. doi: 10.3390/ijms11052039. Int J Mol Sci. 2010. PMID: 20559500 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources